Traditional Robots Segment to Dominate Asia Pacific Pharmaceutical Robots Market during 2021-2028
According to The Insight Partners market research study on “Asia Pacific Pharmaceutical Robots Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast – by Product, Application, End User and Country,” is expected to reach US$ 166.81 million by 2028 from US$ 67.59 million in 2021. The market is estimated to grow at a CAGR of 13.8% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific pharmaceutical robots market along with the drivers and restraints pertaining to the market growth. Advantages of incorporating robots in pharmaceutical manufacturing, increasing popularity of robotic systems in manufacturing process and heightening investments in pharmaceutical research and development are major factors driving the growth of the Asia Pacific pharmaceutical robots market. However, incrementing cost of robots and absence of skilled professionals in automated manufacturing units may hinder the growth of Asia Pacific pharmaceutical robots market.
Countries in the Asia Pacific are facing challenges due to increasing incidences of COVID-19 in the second wave of the pandemic. The pharmaceutical robots offer plentiful benefits to the patients and pharmacies and the key members of the healthcare team. Automated systems also have inordinate cost-effective and safety benefits, and they rationalize the pharmacy types by improving data workflow. Moreover, according to report published in August 2020, Indian pharma needs to expedite its adoption of digitization and automation in manufacturing and supply chain management. In this regard, the sector is working on the areas of Internet of Things and Artificial Intelligence to embed these technologies into machine and manufacturing technology to be on par with the Asia Pacific norms. Thus, a rising infection rate has boosted the demand for medications. This increasing infection count has shown a positive impact on the demand for pharmaceutical robots. Therefore, the healthcare facilities and pharmacies are preferring these robots that have boosted their demand.
The market for Asia Pacific pharmaceutical robots is segmented into product, application, end user and country. Based on product, the market is segmented into collaborative pharmaceutical robots, and traditional robots. The traditional robots segment is further sub-segmented into delta robots, articulated robots, cartesian robots, SCARA robots and others. In 2021, the traditional robots segment held the largest share in Asia Pacific pharmaceutical robots market. Based on application, the Asia Pacific pharmaceutical robots market is divided into inspection of pharmaceutical drugs, laboratory applications, and picking & packaging. The inspection of pharmaceutical drugs segment is expected to be the fastest growing segment over the forecast period. Based on end user, the market is segmented into pharmaceutical companies, research laboratories and contract research organizations. In 2021, the pharmaceutical companies segment held the largest share in Asia Pacific pharmaceutical robots market. Based on country, the Asia Pacific pharmaceutical robots market is divided into China, Japan, India, Australia, South Korea and rest of Asia Pacific. In 2021, Japan held the largest share in Asia Pacific pharmaceutical robots market..
ABB, Kawasaki Heavy Industries, Ltd., Yaskawa Electric Corporation, Universal Robots, Marchesini Group S.p.A, Denso Corporation, Fanuc Corporation, Seiko Epson Corporation, Shibuya Corporation, and Weiss GmbH are some of the leading companies in the Asia Pacific pharmaceutical robots market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com